TADA1

Across TCGA pan-cancer cohorts, TADA1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TADA1 data layer compared with 26 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher TADA1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated TADA1 expression acts as an unfavorable survival marker.

HNSC, PDAC, and LUAD are the cancer types where TADA1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	All	0.349	1.000	.009	16	view →
PDAC	OS	Tertile	III,IV	0.209	0.679	.047	3	view →
LUAD	DFS	Median	III,IV	0.432	0.925	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

TADA1–HNSC (DFS)

Open the HNSC breakdown →